Cutler Group LP 180 Life Sciences Corp. Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$0.12 - $1.31 $871 - $9,510	7,260 Added 124.38%	13,097 $8,000
Q2 2022 Aug 04, 2022	BUY	$0.81 - $2.53 $29 - $93	37 Added 0.64%	5,837 $4,000
Q1 2022 Apr 14, 2022	SELL	$2.53 - $3.9 $2,277 - $3,510	-900 Reduced 13.43%	5,800 $15,000
Q4 2021 Jan 18, 2022	SELL	$3.27 - $6.38 $4,905 - $9,570	-1,500 Reduced 18.29%	6,700 $26,000
Q3 2021 Oct 26, 2021	SELL	$5.11 - $10.81 $30,215 - $63,919	-5,913 Reduced 41.9%	8,200 $44,000
Q2 2021 Jul 19, 2021	BUY	$6.7 - $11.98 $94,557 - $169,073	14,113 New	14,113 $141,000

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $81.1M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.